{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,20]],"date-time":"2026-11-20T18:41:36Z","timestamp":1795200096106,"version":"4.10.3"},"reference-count":49,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2014,3,1]],"date-time":"2014-03-01T00:00:00Z","timestamp":1393632000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2014,3]]},"DOI":"10.1016\/j.vaccine.2014.01.011","type":"journal-article","created":{"date-parts":[[2014,1,23]],"date-time":"2014-01-23T10:00:51Z","timestamp":1390471251000},"page":"1273-1279","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":49,"title":["Quantification by LC\u2013MSE of outer membrane vesicle proteins of the Bexsero\u00ae vaccine"],"prefix":"10.1016","volume":"32","author":[{"given":"Chiara","family":"Tani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Stella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danilo","family":"Donnarumma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimiliano","family":"Biagini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierino","family":"Parente","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Vadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Magagnoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Costantino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabio","family":"Rigat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie","family":"Norais","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl 2","key":"10.1016\/j.vaccine.2014.01.011_bib0005","doi-asserted-by":"crossref","first-page":"B51","DOI":"10.1016\/j.vaccine.2009.04.063","article-title":"Global epidemiology of meningococcal disease","volume":"27","author":"Harrison","year":"2009","journal-title":"Vaccine"},{"issue":"5","key":"10.1016\/j.vaccine.2014.01.011_bib0010","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1093\/infdis\/126.5.514","article-title":"Immunologic response of man to group B meningococcal polysaccharide vaccines","volume":"126","author":"Wyle","year":"1972","journal-title":"J Infect Dis"},{"issue":"17\u201319","key":"10.1016\/j.vaccine.2014.01.011_bib0015","doi-asserted-by":"crossref","first-page":"2688","DOI":"10.1016\/S0264-410X(00)00554-5","article-title":"Reverse vaccinology, a genome-based approach to vaccine development","volume":"19","author":"Rappuoli","year":"2001","journal-title":"Vaccine"},{"issue":"5459","key":"10.1016\/j.vaccine.2014.01.011_bib0020","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1126\/science.287.5459.1816","article-title":"Identification of vaccine candidates against serogroup B meningococcus by whole-genome sequencing","volume":"287","author":"Pizza","year":"2000","journal-title":"Science"},{"issue":"Suppl 2","key":"10.1016\/j.vaccine.2014.01.011_bib0025","doi-asserted-by":"crossref","first-page":"B87","DOI":"10.1016\/j.vaccine.2012.01.033","article-title":"The new multicomponent vaccine against meningococcal serogroup B, 4CMenB: immunological, functional and structural characterization of the antigens","volume":"30","author":"Serruto","year":"2012","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.vaccine.2014.01.011_bib0030","first-page":"67","article-title":"Production, characterization and control of MenB-vaccine Folkehelsa: an outer membrane vesicle vaccine against group B meningococcal disease","volume":"14","author":"Fredriksen","year":"1991","journal-title":"NIPH Ann"},{"issue":"7","key":"10.1016\/j.vaccine.2014.01.011_bib0035","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1517\/14712598.2011.585965","article-title":"Recombinant protein meningococcal serogroup B vaccine combined with outer membrane vesicles","volume":"11","author":"Bai","year":"2011","journal-title":"Expert Opin Biol Ther"},{"issue":"2","key":"10.1016\/j.vaccine.2014.01.011_bib0040","doi-asserted-by":"crossref","first-page":"174","DOI":"10.4161\/hv.18500","article-title":"Bexsero: a multicomponent vaccine for prevention of meningococcal disease","volume":"8","author":"Gorringe","year":"2012","journal-title":"Hum Vaccin Immunother"},{"issue":"3","key":"10.1016\/j.vaccine.2014.01.011_bib0045","doi-asserted-by":"crossref","first-page":"282","DOI":"10.4161\/hv.19916","article-title":"MenB candidate vaccine Bexsero induces robust immune response in infants","volume":"8","author":"Riedmann","year":"2012","journal-title":"Hum Vaccin Immunother"},{"issue":"17\u201318","key":"10.1016\/j.vaccine.2014.01.011_bib0050","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1016\/j.vaccine.2005.01.063","article-title":"MeNZB: a safe and highly immunogenic tailor-made vaccine against the New Zealand Neisseria meningitidis serogroup B disease epidemic strain","volume":"23","author":"Oster","year":"2005","journal-title":"Vaccine"},{"issue":"8775","key":"10.1016\/j.vaccine.2014.01.011_bib0055","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1016\/0140-6736(91)91961-S","article-title":"Effect of outer membrane vesicle vaccine against group B meningococcal disease in Norway","volume":"338","author":"Bjune","year":"1991","journal-title":"Lancet"},{"issue":"9","key":"10.1016\/j.vaccine.2014.01.011_bib0060","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/0264-410X(94)00037-N","article-title":"Efficacy, safety, and immunogenicity of a meningococcal group B (15:P1.3) outer membrane protein vaccine in Iquique, Chile, Chilean National Committee for Meningococcal Disease","volume":"13","author":"Boslego","year":"1995","journal-title":"Vaccine"},{"issue":"8827","key":"10.1016\/j.vaccine.2014.01.011_bib0065","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1016\/0140-6736(92)93086-3","article-title":"Protective efficacy of a serogroup B meningococcal vaccine in Sao Paulo, Brazil","volume":"340","author":"de Moraes","year":"1992","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.vaccine.2014.01.011_bib0070","first-page":"195","article-title":"Vaccine against group B Neisseria meningitidis: protection trial and mass vaccination results in Cuba","volume":"14","author":"Sierra","year":"1991","journal-title":"NIPH Ann"},{"issue":"1","key":"10.1016\/j.vaccine.2014.01.011_bib0075","doi-asserted-by":"crossref","first-page":"23","DOI":"10.4161\/hv.4.1.4806","article-title":"Characterization of the key antigenic components and pre-clinical immune responses to a meningococcal disease vaccine based on Neisseria lactamica outer membrane vesicles","volume":"4","author":"Finney","year":"2008","journal-title":"Hum Vaccines"},{"issue":"18","key":"10.1016\/j.vaccine.2014.01.011_bib0080","doi-asserted-by":"crossref","first-page":"3211","DOI":"10.1016\/j.vaccine.2010.02.023","article-title":"Characterization of meningococcal serogroup B outer membrane vesicle vaccines from strain 44\/76 after growth in different media","volume":"28","author":"Tsolakos","year":"2010","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.vaccine.2014.01.011_bib0085","doi-asserted-by":"crossref","first-page":"80","DOI":"10.4161\/hv.1.2.1651","article-title":"Characterization of the protein content of a meningococcal outer membrane vesicle vaccine by polyacrylamide gel electrophoresis and mass spectrometry","volume":"1","author":"Vipond","year":"2005","journal-title":"Hum Vaccines"},{"issue":"5","key":"10.1016\/j.vaccine.2014.01.011_bib0090","doi-asserted-by":"crossref","first-page":"347","DOI":"10.4161\/hv.5.5.7367","article-title":"Proteomic study via a non-gel based approach of meningococcal outer membrane vesicle vaccine obtained from strain CU385: a road map for discovering new antigens","volume":"5","author":"Gil","year":"2009","journal-title":"Hum Vaccines"},{"issue":"6","key":"10.1016\/j.vaccine.2014.01.011_bib0095","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1002\/pmic.200500164","article-title":"Outer membrane vesicles from group B Neisseria meningitidis delta gna33 mutant: proteomic and immunological comparison with detergent-derived outer membrane vesicles","volume":"6","author":"Ferrari","year":"2006","journal-title":"Proteomics"},{"issue":"11","key":"10.1016\/j.vaccine.2014.01.011_bib0100","doi-asserted-by":"crossref","first-page":"3400","DOI":"10.1002\/pmic.200500821","article-title":"Proteomic analysis of a meningococcal outer membrane vesicle vaccine prepared from the group B strain NZ98\/254","volume":"6","author":"Vipond","year":"2006","journal-title":"Proteomics"},{"issue":"Suppl 3","key":"10.1016\/j.vaccine.2014.01.011_bib0105","first-page":"s140","article-title":"Proteomics investigation of human platelets by shotgun nUPLC\u2013MSE and 2DE experimental strategies: a comparative study","volume":"8","author":"Finamore","year":"2010","journal-title":"Blood Transfus"},{"issue":"5","key":"10.1016\/j.vaccine.2014.01.011_bib0110","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1074\/mcp.M600303-MCP200","article-title":"Analysis and quantification of diagnostic serum markers and protein signatures for Gaucher disease","volume":"6","author":"Vissers","year":"2007","journal-title":"Mol Cell Proteomics"},{"issue":"4","key":"10.1016\/j.vaccine.2014.01.011_bib0115","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1074\/mcp.M500321-MCP200","article-title":"Simultaneous qualitative and quantitative analysis of the Escherichia coli proteome: a sweet tale","volume":"5","author":"Silva","year":"2006","journal-title":"Mol Cell Proteomics"},{"issue":"1","key":"10.1016\/j.vaccine.2014.01.011_bib0120","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1074\/mcp.M500230-MCP200","article-title":"Absolute quantification of proteins by LCMSE: a virtue of parallel MS acquisition","volume":"5","author":"Silva","year":"2006","journal-title":"Mol Cell Proteomics"},{"issue":"15","key":"10.1016\/j.vaccine.2014.01.011_bib0125","doi-asserted-by":"crossref","first-page":"2156","DOI":"10.1016\/j.vaccine.2009.01.099","article-title":"Structural organization of NadADelta(351-405), a recombinant MenB vaccine component, by its physico-chemical characterization at drug substance level","volume":"27","author":"Magagnoli","year":"2009","journal-title":"Vaccine"},{"issue":"7","key":"10.1016\/j.vaccine.2014.01.011_bib0130","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1016\/j.vaccine.2011.12.066","article-title":"Structural characterisation, stability and antibody recognition of chimeric NHBA-GNA1030: an investigational vaccine component against Neisseria meningitidis","volume":"30","author":"Martino","year":"2012","journal-title":"Vaccine"},{"issue":"32","key":"10.1016\/j.vaccine.2014.01.011_bib0135","doi-asserted-by":"crossref","first-page":"4762","DOI":"10.1016\/j.vaccine.2012.05.036","article-title":"Simultaneous quantification of the viral antigens hemagglutinin and neuraminidase in influenza vaccines by LC\u2013MSE","volume":"30","author":"Creskey","year":"2012","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.vaccine.2014.01.011_bib0140","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1111\/irv.12001","article-title":"Label-free mass spectrometry-based quantification of hemagglutinin and neuraminidase in influenza virus preparations and vaccines","volume":"7","author":"Getie-Kebtie","year":"2013","journal-title":"Influenza Other Respir Viruses"},{"issue":"14","key":"10.1016\/j.vaccine.2014.01.011_bib0145","doi-asserted-by":"crossref","first-page":"2475","DOI":"10.1016\/j.vaccine.2011.12.056","article-title":"Simultaneous quantification of hemagglutinin and neuraminidase of influenza virus using isotope dilution mass spectrometry","volume":"30","author":"Williams","year":"2012","journal-title":"Vaccine"},{"issue":"13","key":"10.1016\/j.vaccine.2014.01.011_bib0150","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1093\/bioinformatics\/btq249","article-title":"PSORTb 3.0: improved protein subcellular localization prediction with refined localization subcategories and predictive capabilities for all prokaryotes","volume":"26","author":"Yu","year":"2010","journal-title":"Bioinformatics"},{"issue":"4","key":"10.1016\/j.vaccine.2014.01.011_bib0155","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1093\/bioinformatics\/18.4.641","article-title":"DOLOP\u2014database of bacterial lipoproteins","volume":"18","author":"Madan Babu","year":"2002","journal-title":"Bioinformatics"},{"issue":"7","key":"10.1016\/j.vaccine.2014.01.011_bib0160","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1128\/CVI.00038-06","article-title":"Understanding the immune responses to the meningococcal strain-specific vaccine MeNZB measured in studies of infants","volume":"13","author":"Ruijne","year":"2006","journal-title":"Clin Vaccine Immunol"},{"issue":"9","key":"10.1016\/j.vaccine.2014.01.011_bib0165","doi-asserted-by":"crossref","first-page":"2963","DOI":"10.1128\/IAI.59.9.2963-2971.1991","article-title":"Topology of outer membrane porins in pathogenic Neisseria spp","volume":"59","author":"van der Ley","year":"1991","journal-title":"Infect Immun"},{"issue":"2","key":"10.1016\/j.vaccine.2014.01.011_bib0170","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1128\/IAI.00682-10","article-title":"Lipoproteins of bacterial pathogens","volume":"79","author":"Kovacs-Simon","year":"2011","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2014.01.011_bib0175","doi-asserted-by":"crossref","first-page":"128705","DOI":"10.1100\/2012\/128705","article-title":"Association of Acinetobacter baumannii EF-Tu with cell surface, outer membrane vesicles, and fibronectin","volume":"2012","author":"Dallo","year":"2012","journal-title":"Sci World J"},{"issue":"7","key":"10.1016\/j.vaccine.2014.01.011_bib0180","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1074\/mcp.M800486-MCP200","article-title":"Surfome analysis as a fast track to vaccine discovery: identification of a novel protective antigen for Group B Streptococcus hypervirulent strain COH1","volume":"8","author":"Doro","year":"2009","journal-title":"Mol Cell Proteomics"},{"issue":"2","key":"10.1016\/j.vaccine.2014.01.011_bib0185","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1038\/nbt1179","article-title":"Characterization and identification of vaccine candidate proteins through analysis of the group A Streptococcus surface proteome","volume":"24","author":"Rodriguez-Ortega","year":"2006","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.vaccine.2014.01.011_bib0190","doi-asserted-by":"crossref","DOI":"10.1021\/pr301208g","article-title":"Quantitative proteomics reveals distinct differences in the protein content of outer membrane vesicle vaccines","author":"van de Waterbeemd","year":"2013","journal-title":"J Proteome Res"},{"issue":"23","key":"10.1016\/j.vaccine.2014.01.011_bib0195","doi-asserted-by":"crossref","first-page":"1866","DOI":"10.1001\/jama.1996.03540230016011","article-title":"Serogroup Y meningococcal disease\u2014Illinois, Connecticut, and selected areas, United States, 1989\u20131996","volume":"276","author":"Centers for Disease Control and Prevention","year":"1996","journal-title":"JAMA"},{"issue":"8","key":"10.1016\/j.vaccine.2014.01.011_bib0200","doi-asserted-by":"crossref","first-page":"4028","DOI":"10.1128\/IAI.70.8.4028-4034.2002","article-title":"Immunization with the recombinant PorB outer membrane protein induces a bactericidal immune response against Neisseria meningitidis","volume":"70","author":"Wright","year":"2002","journal-title":"Infect Immun"},{"issue":"1","key":"10.1016\/j.vaccine.2014.01.011_bib0205","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1006\/mpat.1998.0206","article-title":"Omp85 proteins of Neisseria gonorrhoeae and Neisseria meningitidis are similar to Haemophilus influenzae D-15-Ag and Pasteurella multocida Oma87","volume":"25","author":"Manning","year":"1998","journal-title":"Microb Pathog"},{"issue":"Pt 2","key":"10.1016\/j.vaccine.2014.01.011_bib0210","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1099\/jmm.0.004820-0","article-title":"Neisseria meningitidis antigen NMB0088: sequence variability, protein topology and vaccine potential","volume":"58","author":"Sardinas","year":"2009","journal-title":"J Med Microbiol"},{"issue":"9","key":"10.1016\/j.vaccine.2014.01.011_bib0215","doi-asserted-by":"crossref","first-page":"3784","DOI":"10.1128\/IAI.05019-11","article-title":"The Neisseria meningitidis macrophage infectivity potentiator protein induces cross-strain serum bactericidal activity and is a potential serogroup B vaccine candidate","volume":"79","author":"Hung","year":"2011","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2014.01.011_bib0220","doi-asserted-by":"crossref","first-page":"e1000969","DOI":"10.1371\/journal.ppat.1000969","article-title":"An outer membrane receptor of Neisseria meningitidis involved in zinc acquisition with vaccine potential","volume":"6","author":"Stork","year":"2010","journal-title":"PLoS Pathog"},{"issue":"9","key":"10.1016\/j.vaccine.2014.01.011_bib0225","doi-asserted-by":"crossref","first-page":"2475","DOI":"10.1128\/jb.177.9.2475-2480.1995","article-title":"Variable expression of class 1 outer membrane protein in Neisseria meningitidis is caused by variation in the spacing between the \u221210 and \u221235 regions of the promoter","volume":"177","author":"van der Ende","year":"1995","journal-title":"J Bacteriol"},{"issue":"2","key":"10.1016\/j.vaccine.2014.01.011_bib0230","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1111\/j.1365-2958.1994.tb00416.x","article-title":"Variable expression of the Opc outer membrane protein in Neisseria meningitidis is caused by size variation of a promoter containing poly-cytidine","volume":"13","author":"Sarkari","year":"1994","journal-title":"Mol Microbiol"},{"issue":"7","key":"10.1016\/j.vaccine.2014.01.011_bib0235","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1002\/pmic.200800642","article-title":"Identification of proteins of Neisseria meningitidis induced under iron-limiting conditions using the isobaric tandem mass tag (TMT) labeling approach","volume":"9","author":"van Ulsen","year":"2009","journal-title":"Proteomics"},{"issue":"23","key":"10.1016\/j.vaccine.2014.01.011_bib0240","doi-asserted-by":"crossref","first-page":"6594","DOI":"10.1128\/JB.01091-12","article-title":"The zinc-responsive regulon of Neisseria meningitidis comprises 17 genes under control of a Zur element","volume":"194","author":"Pawlik","year":"2012","journal-title":"J Bacteriol"},{"issue":"17\u201318","key":"10.1016\/j.vaccine.2014.01.011_bib0245","doi-asserted-by":"crossref","first-page":"2202","DOI":"10.1016\/j.vaccine.2005.01.058","article-title":"The concept of tailor-made, protein-based, outer membrane vesicle vaccines against meningococcal disease","volume":"23","author":"Holst","year":"2005","journal-title":"Vaccine"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X14000127?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X14000127?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,8,14]],"date-time":"2020-08-14T14:02:19Z","timestamp":1597413739000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X14000127"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,3]]},"references-count":49,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2014,3]]}},"alternative-id":["S0264410X14000127"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2014.01.011","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2014,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Quantification by LC\u2013MSE of outer membrane vesicle proteins of the Bexsero\u00ae vaccine","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2014.01.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}